• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, February 8, 2019

Article

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

POLITICO’s Thursday Morning eHealth report included a study published in the February 2019 issue of The American Journal of Managed Care® (AJMC®). The study, “Does Comparing Cesarean Delivery Rates Influence Women’s Choice of Obstetric Hospital?” found that providing women with an interactive tool to compare cesarean delivery rates across hospitals in their community improved women’s familiarity with variation in cesarean delivery rates but did not increase their likelihood of selecting hospitals with lower rates.

A study published in the January health information technology issue of AJMC®, “Understanding the Relationship Between Data Breaches and Hospital Advertising Expenditures,” was highlighted in an article from DigitalCommerce360. The study, which estimated the relationship between data breaches and hospital advertising expenditures, found that a data breach was associated with a 64% increase in annual advertising expenditures.

The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed mentioned a study published in the February issue of AJMC®, “Process Reengineering and Patient-Centered Approach Strengthen Efficiency in Specialized Care.” The study found that improving efficiency is complex and requires a multimodal approach. The researchers concluded that health information systems, patient feedback, and multidisciplinary teams are components that can improve clinical processes.

Tuesday’s CER Daily Newsfeed included an article from AJMC®. The article, “Getting Ready for the Use of Real-World Evidence,” covered the FDA’s launching of a process that will give real-world data generated outside clinical trials more importance than they have had in the past—with implications for payers, drug companies, and most of all, patients.

Related Videos
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.